Home > Products > Induced Pluripotent Stem Cells (iPSCs) >
HighQC™ Human iPSC Line (Episomal, CB) | ||||
|---|---|---|---|---|
| Product Name | HighQC™ Human iPSC Line (Episomal, CB) | |||
| Price | Get Quote | |||
| Cat.No | ABC-SC003X | Species | Human | |
| Size/Quantity | 1 vial | Biosafety Level | 1 | |
| Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
| Description | The human iPSC line (episomal, CB) is a type of human induced pluripotent stem cell (iPSC) that was derived from human newborn cord blood (CB) mononuclear cells. The cells were reprogrammed into an embryonic-like pluripotent state using a method involving the introduction of OCT4, SOX2, KLF4, L-MYC, and Lin28 genes through episomal plasmids. Cord blood cells are an attractive source of hematopoietic stem cells for transplantation, offering advantages such as easy and risk-free collection, minimal somatic mutations, and the immunological immaturity typically associated with newborn cells. Under standard human ES cell culture conditions, the morphology of these human iPSCs is indistinguishable from that of human embryonic stem cells (ES).
Why choose HighQC™ Human iPSC Line (Episomal, CB) from AcceGen? The human iPSC line (episomal, CB) stands out with its high viability and adaptability to serum-free, feeder-free culture conditions. Each batch of iPSCs is meticulously tested, assessing their growth and viability. Our rigorous quality control measures ensure that the iPSC line is robust and suitable for a wide range of research applications.
| |||
| Disease | Normal | |||
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. | |||
| Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). | |||
| Application | FOR RESEARCH USE ONLY The applications of human induced pluripotent stem cells (iPSCs), specifically the episomal cord blood (CB) iPSC line, are highly valuable in various research areas. iPSCs have significant potential in advancing cell therapy, particularly in the field of regenerative medicine. Researchers are particularly intrigued by the application of iPSC technology in modeling diseases. The ability to model diseases using iPSCs has proven to be a powerful tool for understanding and advancing treatment options. The human iPSC line (episomal, CB) holds great promise for accelerating progress in cell therapy development, regenerative medicine, and the study of blood diseases. | |||
| Growth Conditions | 37 ℃, 5% CO2 | |||
| Cell Type | Induced Pluripotent Stem Cell | |||
| Growth Mode | Adherent | |||
| Product Type | Human iPSCs | |||
| Product Image |  | |||
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
